January 19, 2021
Home  »  Website  »  Sponsored  »  Delhi Traffic Police Get “Summer Mein Sukoon”

Delhi Traffic Police Get “Summer Mein Sukoon”

Google + Linkedin Whatsapp
Follow Outlook India On News
Delhi Traffic Police Get “Summer Mein Sukoon”
Delhi Traffic Police Get “Summer Mein Sukoon”
  • Unique initiative for traffic police of Delhi
  • Identified 12 high traffic locations in Delhi for the activity

With the scorching summer afternoon and managing the heavy traffic flow, the city’s traffic police bear the incessant vehicle honking, wiping off the sweat to ensure a safe and smooth ride for everyone. With a view to provide ‘Summer mein Sukoon’ to the city’s traffic police, ABZORB- the popular anti-fungal powder launched a campaign in Delhi’s high traffic areas engaging with many traffic policemen across the city.  

The campaign was aimed at addressing heat issues faced by traffic police especially during the summer season when temperatures touch record high levels with an increased percentage of humidity in the atmosphere. The traffic in the city has been breaking all records owing to the on-going infrastructural developments taking place at various locations.

The unique initiative had canter vans of ABZORB, a product of Sun Pharma’s consumer healthcare division, placed at major traffic signals/circles. These vans were stationed at specific places for traffic police and they were counselled with tips to stay hydrated, manage sweat and remain protected from the fungal infections, which are rampant during summers. The vans were placed at various locations in Delhi, majorly focusing on high traffic zones, which included, Kailash Colony, Greater Kailash, Moolchand, Nehru Place, Okhla, Kalkajee, IIT Crossing, Ashram Chowk etc.

A traffic policeman placed at Nehru Place, expressed his views on the initiative, "Delhi temperatures go through the roof in summers and this was a great initiative to take care of the Traffic Police. Getting distracted with the heat is not an option for us and hence, having such initiative really helped.”

According to a TomTom Traffic Index 2018 released recently by TomTom, Delhi is the 4th ranked city to have the worst traffic conditions in the world, where as Mumbai takes the top position out of all the cities ranked in the index. The impact of the traffic congestion is felt by the traffic police who manage movement of vehicles all throughout the day.

ABZORB Anti-Fungal Powder is over-the-counter (OTC) product of Sun Pharma Consumer Healthcare (CHC), a division of Sun Pharmaceutical Industries Ltd.

About Sun Pharma Consumer Healthcare (CHC)

Consumer Healthcare (CHC) is a separate business division engaged in developing and marketing over-the-counter (OTC) products in India. This division offers renowned key brands including two of the top 10 OTC brands – Revital H and Volini. The CHC division is among India’s top 10 consumer healthcare businesses.

About Sun Pharmaceutical Industries Ltd

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 100 countries across the world. Sun Pharma's global presence is supported by 44 manufacturing facilities spread across 6 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. In India, the company enjoys leadership across 10 different classes of doctors with 30 brands featuring amongst top 300 pharmaceutical brands in India. Its footprint across emerging markets covers over 100 markets and 6 markets in Western Europe. Its Global Consumer Healthcare business is ranked amongst Top 10 across 3 global markets. Its API business footprint is strengthened through 14 world class API manufacturing facilities across the globe. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising about 2,000 scientists and R&D investments of approximately 7% of annual revenues. For further information, please visit www.sunpharma.com & follow us on Twitter @SunPharma_Live.

For in-depth, objective and more importantly balanced journalism, Click here to subscribe to Outlook Magazine
Next Story >>
Google + Linkedin Whatsapp

Read More in:

The Latest Issue

Outlook Videos